| USD ($) $ in Millions | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||||||||||
Net income (loss) including noncontrolling interests | $ 29,764 | $ 35,063 | $ 37,354 | ||||||||||||||
Adjustments for noncash transactions | |||||||||||||||||
Depreciation and depletion (includes impairments) | 25,993 | 23,442 | 20,641 | ||||||||||||||
Deferred income tax charges/(credits) | 765 | (865) | 634 | ||||||||||||||
Postretirement benefits expense in excess of/(less than) net payments | (64) | (358) | 90 | ||||||||||||||
Other long-term obligation provisions in excess of/(less than) payments | (1,430) | (1,712) | (1,501) | ||||||||||||||
Dividends received greater than/(less than) equity in current earnings of equity companies | 3,006 | 191 | 509 | ||||||||||||||
Changes in operational working capital, excluding cash and debt | |||||||||||||||||
Notes and accounts receivable reduction/(increase) | (3,042) | (6,030) | 4,370 | ||||||||||||||
Inventories reduction/(increase) | (4,300) | (1,812) | (3,472) | ||||||||||||||
Other current assets reduction/(increase) | (164) | 389 | (426) | ||||||||||||||
Accounts and other payables increase/(reduction) | (222) | 5,627 | (4,727) | ||||||||||||||
Net (gain)/loss on asset sales | (1,113) | (1,223) | (513) | ||||||||||||||
All other items - net | 2,777 | 2,310 | 2,410 | ||||||||||||||
Net cash provided by operating activities | 51,970 | 55,022 | 55,369 | ||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES | |||||||||||||||||
Additions to property, plant, and equipment | (28,358) | (24,306) | (21,919) | ||||||||||||||
Proceeds from asset sales and returns of investments | 3,158 | 4,987 | 4,078 | ||||||||||||||
Decrease/(increase) in restricted cash and cash equivalents | - | - | - | ||||||||||||||
Additional investments and advances | (4,133) | (3,299) | (2,995) | ||||||||||||||
Other investing activities including collection of advances | 3,406 | 1,926 | 1,562 | ||||||||||||||
Cash acquired from mergers and acquisitions | 0 | 754 | - | ||||||||||||||
Collection of advances | - | - | - | ||||||||||||||
Additions to marketable securities | - | - | - | ||||||||||||||
Sales of marketable securities | - | - | - | ||||||||||||||
Net cash used in investing activities | (25,927) | (19,938) | (19,274) | ||||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||||||||||
Additions to long-term debt | 2,311 | 899 | 939 | ||||||||||||||
Reductions in long-term debt | (1,108) | (1,150) | (15) | ||||||||||||||
Additions to short-term debt | 2,359 | 0 | 0 | ||||||||||||||
Reductions in short-term debt | (5,404) | (4,743) | (879) | ||||||||||||||
Additions/(reductions) in commercial paper, and debt with three months or less maturity | 1,895 | (18) | (284) | ||||||||||||||
Contingent consideration payments | (79) | (27) | (68) | ||||||||||||||
Additions/(reductions) in debt with three months or less maturity | - | - | - | ||||||||||||||
Cash dividends to ExxonMobil shareholders | (17,231) | (16,704) | (14,941) | ||||||||||||||
Cash dividends to noncontrolling interests | (935) | (658) | (531) | ||||||||||||||
Changes in noncontrolling interests | (704) | (791) | (770) | ||||||||||||||
Inflows from noncontrolling interests for major projects | 88 | 32 | - | ||||||||||||||
Tax benefits related to stock-based awards | - | - | - | ||||||||||||||
Common stock acquired | (20,273) | (19,629) | (17,748) | ||||||||||||||
Common stock sold | - | - | - | ||||||||||||||
Net cash provided by (used in) financing activities | (39,081) | (42,789) | (34,297) | ||||||||||||||
Effects of exchange rate changes on cash | 532 | (676) | 105 | ||||||||||||||
Increase/(decrease) in cash and cash equivalents (including restricted) | $ (12,506) | $ (8,381) | $ 1,903 |